Report Highlights
The global market for point of care diagnosis should grow from $24.8 billion in 2021 to $43.5 billion by 2026 with a compound annual growth rate (CAGR) of 11.9% for the period of 2021-2026.
Report Includes
- 59 data tables and 40 additional tables
- An overview of the global markets and technologies for point of care (POC) diagnostics within healthcare industry
- Estimation of market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation of current market trends, and technological advancements within the industry and market share analysis by test type, product, end user, and region
- Coverage of novel approaches for the POC; discussion on significance of CLIA in the United States and FDA’s role in POC testing; and information on laser PCR
- Detailed description about COVID-19 impact on MedTech and medical tourism, discussion on FDA’s contribution to COVID-19 diagnostic testing and synopsis of FDA-Associated testing milestones since May 2020
- Detailed analysis of relevant R&D activities, new products launches and product enhancement in the industry, clinical trials, and discussion of regulatory elements that are affecting the future marketplace
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players of the industry, including Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Medtronic plc, Chembio Diagnostics Inc. and Philips Healthcare
Report Scope
The current report offers a detailed picture of the point of care diagnostics market.
This report highlights the current and future market potential for point of care diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2026, as well as key market players.
This report discusses the point of care diagnostics industry and its various resources. It covers the overall point of care diagnostics market including hardware (devices, equipment, consumables (reagents and kits)), software and analytics. The report further analyzes the market based on test type, providing an analysis of alcohol and drug abuse, BGEM, cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious disease, pregnancy and fertility, tumor markers, urine chemistry and others. A complete regional analysis of the market is also studied in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. Detailed analyses of major countries include the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India. For market estimates, data have been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Smart Medical Devices: Global Markets (MDS066B)
- Global Data Center Market (IFT320A)
- Healthcare Innovation in the GCC (HLC307A)
- Global Markets for Infectious Disease Treatments (PHM061F)
- Global Graphene Market (AVM255A)
Related Reports
The Global Influenza Market
The global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029.
Therapeutics for Women's Health: Technologies and Global Markets
The global therapeutics for women’s health technologies market is expected to grow from $61.5 billion in 2024 and is projected to reach $81.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2029.
In Vitro Diagnostics: Technologies and Global Markets
The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Healthcare Innovation in the GCC
The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.
Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa
This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.
Global Markets for Telemedicine Technologies
The global market for telemedicine technologies is projected to grow from $146.9 billion in 2025 to $251.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2030.
Thermo Fisher Scientific Inc.: 360° Company Analysis
This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.
Report Highlights
The global market for point of care (POC) diagnostics and testing should grow from $19.3 billion in 2018 to $25.5 billion by 2023 with a compound annual growth rate (CAGR) of 5.7% from 2018 to 2023.
Report Includes
- 43 data tables and 19 additional tables
- An overview of the global markets for point of care (POC) diagnostics and testing within healthcare industry
- Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- A look at the diagnostic testing industry featuring current trends, government regulations and growth drivers that will shape the future POC testing market
- Assessment of competitive landscape and current product suppliers and some of their technologies and market shares within the POC industry
- Patent study and analysis covering all significant developments in POC technologies
- Company profiles of major global players within the POC market, including Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Co., Danaher Corp., Roche and Siemens Medical Solutions
Report Highlights
The global point of care (POC) diagnostics market was valued at nearly $16.8 billion and $18.0 billion in 2014 and 2015, respectively. This market is expected to grow from $19.3 billion in 2016 to $28.3 billion in 2021 at a compound annual growth rate (CAGR) of 8.0% for 2016-2021.
Report Includes
- An overview of the global markets for point of care diagnostics.
- Analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Discussion of factors driving the market including staff shortages, older populations, long-term cost savings, and need for faster diagnosis and care.
- A look at how availability of POC testing has revolutionized the continuum of the patient-care process.
- In depth analysis of the major force driving the growth of this industry, the effort to provide better patient care by improving the turn-around-time (TAT) that POC testing offers.
- A look at the other market factors including growth restraints and opportunities.
- Profiles of major players in the industry.
Report Highlights
BCC Research estimates the global market for point-of-care (POC) diagnostics to have been almost $15.1 billion in 2012. The market should reach $15.5 billion in 2013 and $19.3 billion in 2018, a compound annual growth rate (CAGR) of 4.5% over the next five years.
Report Includes
- An overview of the global market for point of care diagnostics.
- Analyses of global market trends, with data from 2012 and 2013, and estimates and projections of CAGRs through 2018.
- Discussion of factors driving the market including staff shortages, older populations, long-term cost savings, and need for faster diagnosis and care.
- A look at how availability of POC testing has revolutionized the continuum of the patient-care process.
Report Highlights
The global point-of-care (POC) diagnostics market reached $13.4 billion in 2010 and is expected to reach $13.8 billion in 2011. It will further grow to $16.5 billion in 2016 for a compound annual growth rate (CAGR) of 3.7% between 2011 and 2016.
Report Highlights
- Global POC market was worth nearly $13.4 billion in 2009, it is estimated to increase to $18.7 billion, at 5 year compound annual growth rate (CAGR) of 7.0%.
- The largest test blood chemistry and electrolyte market was nearly $2.1 billion in 2009. This is expected to rise to $3.8 billion in 2014, at a CAGR of 12.0%.
- Glucose monitoring test market reached approximately $7.7 million in 2009 and is projected to reach $9.9 billion in 2014, at a CAGR of 5.1%.
Report Highlights
-
POC testing revenue reached an estimated $5.05 billion in 2005 and is expected to grow at a 13.8% AAGR through 2010, yielding sales of nearly $9.65 billion.
-
A major force driving the growth of this industry is the effort to provide better patient care by improving the time to treatment (TAT) that POC testing offers. Other forces include cost containment, the aging population, the increased incidence of certain diseases, and technological advances.
-
Glucose testing meters and supplies accounted for 47.9% of POC sales in 2005 and are expected to grow at a 9.4% AAGR through 2010. The worldwide incidence of diabetes is predicted to double in the next 25 years.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More